Katherine Stueland, CEO: GeneDx Holdings WGS Sell · Filed 23/09/19

Trade details

Type: Insider sale
Amount: $44,728.32
Shares · price: 10,752 sh · $4.16 a share
Held after: 42,689 sh
Stock: GeneDx Holdings WGS
Person: Katherine StuelandCEO
Trade date: 23/09/18
Filed: 23/09/19
Days to filing: 1 days

Sold 20.1% of holdings

Share of holding sold: 20.1%

GeneDx Holdings trades, last 26 weeks

What else happened in GeneDx Holdings around then

Filed or reported within 30 days of the trade day · 23/08/19~23/10/18

Katherine Stueland's recent trades

Katherine StuelandCEO
Planned saleGeneDx Holdings
Planned sale
GeneDx Holdings
WGS
$1.2M
14,243 sh
$1.2M
Filed 09/01
Traded 09/09
Katherine StuelandCEO
SellGeneDx Holdings
Sell
GeneDx Holdings
WGS
$360.8K
5,932 sh
$360.8K
Filed 06/18
Traded 06/16
Katherine StuelandCEO
SellGeneDx Holdings
Sell
GeneDx Holdings
WGS
$149.4K
2,429 sh
$149.4K
Filed 06/18
Traded 06/16
Katherine StuelandCEO
SellGeneDx Holdings
Sell
GeneDx Holdings
WGS
$127.9K
2,140 sh
$127.9K
Filed 06/18
Traded 06/16
Katherine StuelandCEO
SellGeneDx Holdings
Sell
GeneDx Holdings
WGS
$195.7K
3,639 sh
$195.7K
Filed 06/11
Traded 06/09

Katherine Stueland, CEO — sold $44.7K of GeneDx Holdings WGS · 20.1% of holdings | Whalegun